| GWAS |
- Adverse response to drug ( 30420678
)
- Alzheimer's disease (late onset) ( 26339675
)
- Asthma (corticosteroid response) ( 24486069
)
- Brain morphology (MOSTest) ( 32665545
)
- Cortical surface area (MOSTest) ( 32665545
)
- Diisocyanate-induced asthma ( 25918132
)
- Economic and political preferences (feminism/equality) ( 22566634
)
- Haemorrhoidal disease ( 33888516
)
- Obesity-related traits ( 23251661
)
- Post bronchodilator FEV1/FVC ratio in COPD ( 26634245
)
- Pulse pressure ( 27841878
)
- Response to fenofibrate (total cholesterol levels) ( 27002377
)
- Subcortical volume (MOSTest) ( 32665545
)
- Systolic blood pressure ( 27841878
)
- Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes ( 28736931
)
- Venous thromboembolism adjusted for sickle cell variant rs77121243-T ( 28203683
)
- Visceral fat ( 22589738
)
|
- Alzheimer's disease ( 34099642
)
- Cerebrospinal fluid α-synuclein levels ( 29959729
)
- Glaucoma (primary open-angle) ( 33627673
)
- HDL cholesterol levels in HIV infection ( 33109212
)
- Longitudinal change in brain amyloid plaque burden ( 26268530
)
- Spatial processing ( 31596458
)
|
